Latest — Page 29

Deals

AbbVie Buys $1.45B Option on Kestrel's KRAS Program

AbbVie Buys $1.45B Option on Kestrel's KRAS Program
FDA

Boehringer-Zealand Obesity Drug Posts 13.4%, Trails Zepbound

Boehringer-Zealand Obesity Drug Posts 13.4%, Trails Zepbound
FDA

Cleared 2 Phase 3 Trials, Incyte Plans Povorcitinib Vitiligo Filing

Cleared 2 Phase 3 Trials, Incyte Plans Povorcitinib Vitiligo Filing
FDA

FDA Moves to Strip Amgen's $459M Tavneos Over Manipulated Data

FDA Moves to Strip Amgen's $459M Tavneos Over Manipulated Data
Legal

Charged: Scattered Spider's 'Bouquet,' 19, Faces 6 Federal Counts

Charged: Scattered Spider's 'Bouquet,' 19, Faces 6 Federal Counts
FDA

Passed Phase 3: Rezzayo Puts CorMedix's $300M Melinta Buy to Work

Passed Phase 3: Rezzayo Puts CorMedix's $300M Melinta Buy to Work
Deals

Sun Pharma Bought Organon for $11.75B, Debt Included

Sun Pharma Bought Organon for $11.75B, Debt Included
FDA

Filed: Intellia lonvo-z BLA on 87% HAE Attack Data

Filed: Intellia lonvo-z BLA on 87% HAE Attack Data
Deals

Lilly Bought Ajax for $2.3B on a JAK2 Resistance Bet

Lilly Bought Ajax for $2.3B on a JAK2 Resistance Bet
FDA

Intellia Files FDA After Lonvo-z Cuts Attacks 87%

Intellia Files FDA After Lonvo-z Cuts Attacks 87%
Legal

Jailed 70 Months, Tangeman Helped Launder $230M Bitcoin Heist

Jailed 70 Months, Tangeman Helped Launder $230M Bitcoin Heist
FDA

FDA Issues 3 Psychedelic Priority Vouchers; Definium Left Out

FDA Issues 3 Psychedelic Priority Vouchers; Definium Left Out
Legal

ShinyHunters Extorts ADT on 10M Records With April 27 Deadline

ShinyHunters Extorts ADT on 10M Records With April 27 Deadline
FDA

FDA Issues 3 Psychedelic Fast-Track Vouchers; Wall Street Blindsided

FDA Issues 3 Psychedelic Fast-Track Vouchers; Wall Street Blindsided
Deals

Lilly Bought In Vivo CAR-T as Sanofi Faces Reckoning

Lilly Bought In Vivo CAR-T as Sanofi Faces Reckoning